Multiinstitutional Open Label Randomized Phase II Study Comparing Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy as Firstline Treatment for Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-NHSCC).
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 07 Dec 2015 Status changed from recruiting to discontinued as results published in the Journal of Clinical Oncology.
- 07 Dec 2015 Results published in the Journal of Clinical Oncology.
- 15 Oct 2010 New trial record